David Raben, M.D.

David Raben, M.D.

Chief Medical OfficeratBicara Therapeutics· In the 2025 proxy

Pay in FY2025Bicara Therapeutics stock -3.4% the same year

David Raben, M.D. was paid $709.2K in FY2025 (Dec). Bicara Therapeutics stock fell 3.4% that year.

Pay$100 in the stock at the end of FY24 → $97
Pay is from the Summary Compensation Table of each Bicara Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Bicara TherapeuticsPublic company · 1 yr
    • Chief Medical Officer2025 – Present · 1 yrStock in role -49%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?